These launches are what Oelrich called “must-win battles” at Bayer as the Xarelto loss of exclusivity reaches “full swing” in ...
A Washington jury on Tuesday ordered Bayer to pay $100 million to four people who say they were sickened by toxic chemicals ...
The trend toward larger deal sizes is likely to continue as companies seek to bolster their pipelines amid a looming patent ...
On the occasion of the 43rd J.P. Morgan Healthcare Conference in San Francisco, Bayer AG announces further progress in its pharmaceutical growth strategy with multiple regulatory filing submissions ...
Bemdaneprocel will be studied in a sham-surgery controlled, double-blind trial that is expected to start in the first half of ...
Bayer will focus on paying down debt and not make any major acquisitions in the next two or three years, the head of the ...
Bayer AG plans to push pause on some of its pharmaceutical dealmaking, focusing instead on reducing the high debt load the ...
A Washington jury has ordered Bayer to pay $100 million to four plaintiffs sickened by PCBs at a Seattle-area school. However, the company was not held liable for claims by 11 others. Bayer, which ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback